Courtagen Life Sciences, Inc. Enters Into an Exclusive Distribution Agreement With the Alliance Global Group
Published: Nov 15, 2012
DUBAI & WOBURN, Mass.--(BUSINESS WIRE)--Courtagen Life Sciences Inc. announced today they have signed an exclusive strategic distribution agreement with the Alliance Global Group (AGBL) to help clinicians in emerging markets diagnose and manage a number of genetically based disorders. Courtagen’s test menu currently offers clinical tests for mitochondrial disorders (mtSEEK™ and nucSEEK™) and a newly released panel for epilepsy and seizure (epiSEEK™). Courtagen plans to add a number of key tests for other important neurological disorders.